Hives that keep coming back are usually not an allergy — they are your own immune system

If your hives keep returning week after week with no obvious cause, the honest answer is that in most cases there is no external cause to find. Chronic spontaneous urticaria (CSU) is defined as wheals, angioedema, or both, arising with no identifiable external trigger [s1]. The international urticaria guideline describes it as a mast cell-driven disease; the lifetime prevalence of acute urticaria alone is approximately 20% [s1]. The recurring kind is a longer, different problem, and understanding why it recurs is what points to the treatment that works.

The cause is usually inside, not outside

People with chronic hives spend enormous effort hunting the food, detergent or fabric behind them. For CSU that hunt is mostly futile, because the disease is now understood as a disorder of the immune system misfiring against the body's own tissues. A 2026 review sets out two major endotypes: autoallergic (type I) CSU, driven by IgE autoantibodies aimed at self-antigens, and autoimmune (type IIb) CSU, driven by IgG autoantibodies targeting IgE or its receptor FcεRI on mast cells and basophils [s2]. Type IIb is the harder version — it is associated with more severe disease, autoimmune comorbidities, low total IgE, and reduced response to both antihistamines and omalizumab [s2].

Even that two-endotype picture is incomplete. The same review describes non-antibody routes to mast-cell activation: the MRGPRX2 receptor, neuroimmune signalling, activation of the coagulation and complement cascades, and persistent low-grade inflammation, with gut-microbiome changes and a leaky epidermal barrier implicated in sustaining it [s2]. In other words, the weals keep coming back because the mast cells sit at a lowered activation threshold, ready to fire on internal signals. That is why an elimination diet so often changes nothing.

What actually settles it, step by step

The guideline recommends a clear ladder. First-line is a modern, non-sedating H1-antihistamine at the standard dose, and if that fails, the same drug up-dosed rather than a sedating alternative [s1]. The Cochrane review of H1-antihistamines identified 73 studies with 9759 participants [s3]. Cetirizine 10 mg once daily produced complete suppression of urticaria in more people than placebo, with a risk ratio of 2.72 (95% confidence interval 1.51 to 4.91) [s3]. Rupatadine at 10 mg and 20 mg achieved a 'good or excellent' response against placebo, risk ratio 1.35 (1.03 to 1.77) [s3]. The estimates are real but modest, and many people are not cleared by antihistamines at any dose — the same fact the pathogenesis explains.

For those, the guideline's next step is omalizumab, an anti-IgE antibody. Its pivotal phase 3 trial randomised 323 patients who remained symptomatic despite antihistamines to injections of 75 mg, 150 mg, 300 mg or placebo, spaced four weeks apart [s4]. On a weekly itch-severity score running from 0 to 21, the baseline was about 14 in every group [s4]. At week 12 the mean change was −5.1 on placebo, −5.9 at 75 mg (P=0.46), −8.1 at 150 mg (P=0.001) and −9.8 at 300 mg (P<0.001) [s4]. The dose response is the story: only the two higher doses clearly beat placebo, and the 300 mg dose roughly doubled the relief. Serious adverse events were uncommon, though the rate was higher at 300 mg (6%) than on placebo (3%) [s4].

The realistic timeline, and the red flag

Chronic hives are treatable but rarely cured on demand. Because the driver is an internal immune state rather than an exposure, the aim of treatment is control while the condition runs its course — which can be months to years — not the removal of a trigger. Antihistamines up-dosed, then omalizumab, is the evidence-backed sequence, and antihistamines remain worth taking even when they only partly work.

One symptom is not something to manage at home. Angioedema — deep swelling — of the lips, tongue or throat, or any hives accompanied by breathing difficulty, faintness or a swollen throat, can be anaphylaxis and is a medical emergency; call for emergency help rather than waiting it out. Hives that come with fever, joint pain, or individual weals that last more than 24 hours and leave a bruise also need a doctor, because they point away from ordinary CSU. For the common, maddening, itchy-but-otherwise-well pattern, the reassuring part is that it is not a sign you are being poisoned by something you ate — and that there is a treatment ladder that works for most people who climb it.

This article is informational and is not medical advice.

Sources

• [s1] The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria — Allergy, 20 October 2021. https://doi.org/10.1111/all.15090
• [s2] Insights into Pathogenesis of Chronic Spontaneous Urticaria — British Journal of Dermatology, 15 July 2026. https://doi.org/10.1093/bjd/ljag277
• [s3] H1-antihistamines for chronic spontaneous urticaria — Cochrane Database of Systematic Reviews, 14 November 2014. https://doi.org/10.1002/14651858.CD006137.pub2
• [s4] Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria — New England Journal of Medicine, 7 March 2013. https://doi.org/10.1056/NEJMoa1215372